Search

Author/Creator Weisel, K.

11. P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN-LABEL DOSE ESCALATION STUDY. (23rd June 2022)

Authors:
van de Donk, N. W.; Guo, S.; Shi, L.; Lord-Bessen, J.; Tang, D.; Karlin, L.; Weisel, K.; Ramasamy, K.; Abad, P. C.; Amin, A.; Amin, S.; Lonial, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1620
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY. (23rd June 2022)

Authors:
Spencer, A.; Moreau, P.; Mateos, M.-V.; Goldschmidt, H.; Suzuki, K.; Levin, M.-D.; Sonneveld, P.; Yoon, S.-S.; Usmani, S. Z.; Weisel, K.; Reece, D.; Ahmadi, T.; Pei, H.; Garvin Mayo, W.; Gai, X.; Carey, J.; Carson, R.; Dimopoulos, M. A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
823
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSES FROM THE LOCOMMOTION STUDY. (23rd June 2022)

Authors:
Einsele, H.; Moreau, P.; De Stefano, V.; Dytfeld, D.; Angelucci, E.; Benjamin, R.; Goldschmidt, H.; van de Donk, N. W.; Besemer, B.; Scheid, C.; Vij, R.; '. Groen-Damen, E. I.; Semerjian, M.; Strulev, V.; Schecter, J. M.; Roccia, T.; Nesheiwat, T.; Wapenaar, R.; Weisel, K.; Mateos, M.-V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
848
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY. (23rd June 2022)

Authors:
Einsele, H.; Moreau, P.; Delforge, M.; van de Donk, N. W.; Ghilotti, F.; Diels, J.; Elsada, A.; Strulev, V.; Pei, L.; Kobos, R.; Smit, J.; Slavcev, M.; Weisel, K.; Mateos, M.-V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING IN MM PATIENTS. (23rd June 2022)

Authors:
Avivi, I.; H vesole, D.; Dávila Valls, J.; Usnarska-Zubkiewicz, L.; Milunovic, V.; Bogumiła Osękowska, B. B.; Kopińska, A.; Gentile, M.; MARTÍNEZ, B. P.; Robak, P.; crusoe, E.; LUIS GERARDO, R.; Gajewska, M.; Gergely, V.; Delforge, M.; Cohen, Y.; Alessandro, G.; peña, C.; Shustik, C.; Mikala, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
782
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN COMBINATION WITH DARATUMUMAB. (23rd June 2022)

Authors:
van de Donk, N. W.; Bahlis, N.; Mateos, M.-V.; Weisel, K.; Dholaria, B.; Garfall, A. L.; Goldschmidt, H.; Martin, T. G.; Morillo, D.; Reece, D. E.; Hurd, D.; Rodríguez-Otero, P.; Bhutani, M.; D'Souza, A.; Oriol, A.; Askari, E.; San-Miguel, J. F.; Kortüm, K. M.; Vishwamitra, D.; Xin Wang Lin, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID‐19 in a tertiary center – A monocentric analysis. (15th February 2023)

Authors:
Schaefers, C.; Paulsen, F.‐O.; Frenzel, C.; Weisel, K.; Bokemeyer, C.; Seidel, C.
Journal:
British journal of haematology
Issue:
Volume 201:Number 2(2023)
Page Start:
222
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE (DVD) VS BORTEZOMIB AND DEXAMETHASONE (VD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): EFFICACY AND SAFETY UPDATE (CASTOR). (June 2017)

Authors:
Lentzsch, S.; Weisel, K.; Mateos, M.V.; Hungria, V.; Munder, M.; Nooka, A.; Mark, T.; Quach, H.; Scott, E.; Lee, J.; Sonneveld, P.; Casneuf, T.; Chiu, C.; Qin, X.; Amin, H.; Thiyagarajah, P.; Schecter, J.; Qi, M.; Spencer, A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗